These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28732520)

  • 1. Characterization of background noise in capture-based targeted sequencing data.
    Park G; Park JK; Shin SH; Jeon HJ; Kim NKD; Kim YJ; Shin HT; Lee E; Lee KH; Son DS; Park WY; Park D
    Genome Biol; 2017 Jul; 18(1):136. PubMed ID: 28732520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation.
    Costello M; Pugh TJ; Fennell TJ; Stewart C; Lichtenstein L; Meldrim JC; Fostel JL; Friedrich DC; Perrin D; Dionne D; Kim S; Gabriel SB; Lander ES; Fisher S; Getz G
    Nucleic Acids Res; 2013 Apr; 41(6):e67. PubMed ID: 23303777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA lesions associated with cell-free DNA by targeted deep sequencing.
    Shin SH; Park WY; Park D
    BMC Med Genomics; 2021 Jul; 14(1):192. PubMed ID: 34320984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of error profiles in deep next-generation sequencing data.
    Ma X; Shao Y; Tian L; Flasch DA; Mulder HL; Edmonson MN; Liu Y; Chen X; Newman S; Nakitandwe J; Li Y; Li B; Shen S; Wang Z; Shurtleff S; Robison LL; Levy S; Easton J; Zhang J
    Genome Biol; 2019 Mar; 20(1):50. PubMed ID: 30867008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MERIT reveals the impact of genomic context on sequencing error rate in ultra-deep applications.
    Hadigol M; Khiabanian H
    BMC Bioinformatics; 2018 Jun; 19(1):219. PubMed ID: 29884116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter.
    Kukita Y; Ohkawa K; Takada R; Uehara H; Katayama K; Kato K
    PLoS One; 2018; 13(2):e0192611. PubMed ID: 29451897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications.
    Arbeithuber B; Makova KD; Tiemann-Boege I
    DNA Res; 2016 Dec; 23(6):547-559. PubMed ID: 27477585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing artifacts derived from a library preparation method using enzymatic fragmentation.
    Tanaka N; Takahara A; Hagio T; Nishiko R; Kanayama J; Gotoh O; Mori S
    PLoS One; 2020; 15(1):e0227427. PubMed ID: 31899787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
    Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
    Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
    Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
    BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-strand specific nuclease enhances accuracy of error-corrected sequencing and improves rare mutation-detection sensitivity.
    Otsubo Y; Matsumura S; Ikeda N; Yamane M
    Arch Toxicol; 2022 Jan; 96(1):377-386. PubMed ID: 34767040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
    Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller.
    Xu C; Nezami Ranjbar MR; Wu Z; DiCarlo J; Wang Y
    BMC Genomics; 2017 Jan; 18(1):5. PubMed ID: 28049435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations.
    Zhou S; Jones C; Mieczkowski P; Swanstrom R
    J Virol; 2015 Aug; 89(16):8540-55. PubMed ID: 26041299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of a mitogenome capture and Illumina sequencing protocol using non-probative, case-type skeletal samples: Implications for the use of a positive control in a next-generation sequencing procedure.
    Marshall C; Sturk-Andreaggi K; Daniels-Higginbotham J; Oliver RS; Barritt-Ross S; McMahon TP
    Forensic Sci Int Genet; 2017 Nov; 31():198-206. PubMed ID: 29101892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples.
    Oh E; Choi YL; Kwon MJ; Kim RN; Kim YJ; Song JY; Jung KS; Shin YK
    PLoS One; 2015; 10(12):e0144162. PubMed ID: 26641479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single molecule targeted sequencing for cancer gene mutation detection.
    Gao Y; Deng L; Yan Q; Gao Y; Wu Z; Cai J; Ji D; Li G; Wu P; Jin H; Zhao L; Liu S; Ge L; Deem MW; He J
    Sci Rep; 2016 May; 6():26110. PubMed ID: 27193446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of custom capture for targeted next-generation DNA sequencing.
    Samorodnitsky E; Datta J; Jewell BM; Hagopian R; Miya J; Wing MR; Damodaran S; Lippus JM; Reeser JW; Bhatt D; Timmers CD; Roychowdhury S
    J Mol Diagn; 2015 Jan; 17(1):64-75. PubMed ID: 25528188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management.
    Zucca S; Villaraggia M; Gagliardi S; Grieco GS; Valente M; Cereda C; Magni P
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):339. PubMed ID: 28185542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.